| abstract |
Compounds of formula I. wherein R¹ and X have the meanings given, their physiologically acceptable salts and / or solvates, inhibit the binding of fibrinogen to the corresponding receptor and can be used for the treatment of thromboses, osteoporoses, tumor diseases, apoplexy, heart attack, inflammation, arteriosclerosis and osteolytic diseases . |